kidney disease glp-1 news drugs calm inflammation beyond diabetes and weight loss What Ozempic and other GLP-1

Explore how the GLP-1 era is reshaping the food industry, driving demand for personalized nutrition, functional ingredients, and portion innovation.

Och A, Och M, Nowak R, Podgrska D, Podgrski R

BMJ-MAGIC Group publishes recommendations for using SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes.

Dual- and triple action approaches which simultaneously target multiple pathways, for example, GLP1R/GIP (tirzepatide), GLP1R/GIP/glucagon (retatrutide) or amylin/GLP1R (CagriSemra) appear more potent and may push weight reduction to the mid-20% range and possibly beyond, while oral options seek to deliver levels of efficacy seen with injectables

Macro tracking and GLP-1s can both be tremendous tools for weight loss, but only when used alongside a number of healthy, sustainable lifestyle habits.